Role of MSX2 in Melanoma
Author Information
Author(s): Gremel G, Ryan D, Rafferty M, Lanigan F, Hegarty S, Lavelle M, Murphy I, Unwin L, Joyce C, Faller W, McDermott E W, Sheahan K, Ponten F, Gallagher W M
Primary Institution: UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
Hypothesis
What is the functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma?
Conclusion
MSX2 may be an important regulator of melanoma cell invasion and survival, with cytoplasmic expression correlating with better prognosis.
Supporting Evidence
- Ectopic expression of MSX2 induced apoptosis in melanoma cells.
- MSX2 over-expression reduced the invasive capacity of melanoma cells.
- Cytoplasmic MSX2 expression correlated with increased recurrence-free survival.
- N-Cadherin downregulation was observed with MSX2 over-expression.
- MSX2 was linked to several signaling pathways affecting cell survival.
Takeaway
MSX2 helps melanoma cells survive and not spread as much, and if it's found in the cytoplasm, it can mean a better chance of recovery for patients.
Methodology
The study used in vitro assays and tissue microarrays to explore the role of MSX2 in melanoma.
Potential Biases
Potential biases in patient selection and histopathological assessment.
Limitations
The study's findings may not be generalizable beyond the specific melanoma cohort examined.
Participant Demographics
Patients diagnosed with primary cutaneous melanoma at St Vincent's University Hospital, Dublin.
Statistical Information
P-Value
0.008
Confidence Interval
0.285–0.840
Statistical Significance
p=0.008
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website